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ABSTRACT 
MODULATION OF MACROPHAGE RESPONSES TO BORRELIA BURGDORFERI 
IN ACUTE MURINE LYME CARDITIS 
MAY 2009 
CHRIS M. OLSON JR. 
B.S., UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE  
Ph.D., UNIVERSITY OF MASSACHUSETTS, AMHERST 
Directed by: Professor Juan Anguita 
 
The Lyme disease spirochete Borrelia burgdorferi is the only known human 
pathogen that directly activates invariant natural killer T (iNKT) cells. The number and 
activation kinetics of iNKT cells vary greatly among different strains of mice. Here, we 
report the role of the iNKT cell response in the pathogenesis of Lyme disease using 
C57BL/6 (B6) mice, a strain with optimal iNKT cell activation that is resistant to the 
development of spirochetal-induced inflammation. During experimental infection of B6 
mice with B. burgdorferi, iNKT cells localize to the inflamed heart where they are 
activated by CD1d-expressing macrophages. Activation of iNKT cells in vivo results in 
the production of IFNγ, which we demonstrate controls the severity of murine Lyme 
carditis by at least two mechanisms. First, IFNγ greatly enhances the recognition of B. 
burgdorferi by macrophages, leading to increased phagocytosis of the spirochete. 
Secondly, IFNγ activation of macrophages increases the surface expression of CD1d, 
thereby facilitating further iNKT activation. Collectively, our data demonstrate that in the 
resistant background, B6, iNKT cells modulate acute murine Lyme carditis through the 
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action of IFNγ, which appears to self-renew through a positive feedback loop during 
infection. 
Inflammation during infection with B. burgdorferi is dependent on the ability of 
the spirochete to evade local mechanisms of clearance. Even though macrophages are the 
main infiltrating cell during Lyme carditis, the identification of a receptor capable of 
mediating phagocytosis of B. burgdorferi has been elusive. Here, we demonstrate that the 
integrin CR3 is able to mediate binding to the spirochete and facilitate phagocytosis in a 
complement-dependent and independent manner. Expression of CR3, but not CR4, in 
CHO cells markedly enhanced their capacity to interact with B. burgdorferi, in the 
absence and presence of complement opsonization. Furthermore, the interaction between 
CR3 and B. burgdorferi is dependent on the metal-ion-dependent adhesion site (MIDAS) 
and could be blocked with EDTA. Inhibition of CR3 with blocking antibody was able to 
completely abrogate phagocytosis of B. burgdorferi by the macrophage-like RAW264.7 
cells and partially block uptake by bone marrow-derived macrophages (BMMs), a finding 
that was recapitulated with CD11b-deficient BMMs. We further show that activation with 
recombinant IFNγ increases the transcription of CD11b and CD18, which correlates with 
increased surface expression of CR3, and that the effect of IFNγ on the phagocytosis of 
B. burgdorferi is circumscribed to CR3 activity, because inhibition of CR3 is able to 
completely diminish the effect of IFNγ on the phagocytosis of the B. burgdorferi. Lastly, 
our results demonstrate that CR3 is a negative regulator of proinflammatory cytokine 
induction in macrophages responding to B. burgdorferi. Overall, our data demonstrate 
roles for CR3 in the binding, phagocytosis and proinflammatory cytokine elicited by B. 
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burgdorferi and shed light on the role of IFNγ in mediating the clearance of the 
spirochete during Lyme disease. 
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CHAPTER I 
THE ROLE OF Vα14-Jα18 INVARIANT NKT CELLS DURING LYME 
BORRELIOSIS 
Introduction 
Lyme disease was first discovered in 1976 as a tick-borne spirochetosis affecting 
a cluster of children in Lyme, Connecticut. In 1982 Dr. Willy Burgdorfer and colleagues 
identified the agent of Lyme disease as a new Gram-negative, extracellular bacterium 
belonging to the eubacteria phylum of spirochetes (24). This spirochete was named 
Borrelia burgdorferi. Since then, it has been established that at least three species of the 
genus Borrelia are agents of Lyme disease. These include B. burgdorferi sensu stricto, B. 
afzelii and B. garinii, which are collectively referred to as B. burgdorferi sensu lato (5, 
25).  Eight minimally pathogenic or nonpathogenic genospecies of B. burgdorferi have 
been identified, which geographically span the United States and Eurasia (Table 1.1) (45, 
67, 81, 90, 91, 110, 134). B. burgdorferi sensu stricto is the etiologic agent of Lyme 
disease in the United States and other parts of the world, while B. afzelii and B. garinii 
are agents of Lyme disease that are restricted to Europe and Asia (5, 25). Infection with 
Lyme disease-causing spirochetes has also been observed in Japan, Russia and China. In 
the United States, transmission of the spirochete is by hard-bodied ticks of the Ixodes 
complex, mainly I. scapularis and I. pacificus. Importantly, Lyme disease is the most 
commonly reported arthropod-borne disease in the United States and Europe.  
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Enzootic life cycle of B. burgdorferi 
B. burgdorferi and its associated genospecies have complex enzootic life cycles 
involving ticks of the Ixodes complex and a wide range of mammals (139). Ixodid ticks 
have three feeding periods during their usual 2-year life cycle. During these periods, ticks 
feed to repletion on the blood of certain vertebrate hosts. In the case of I. scapularis, 
larval ticks feed during the late summer and then molt into a nymphal tick, which feeds 
the following year during late spring or early summer. Larval and nymphal I. scapularis 
ticks feed on certain rodents, including the white-footed mouse and chipmunk (Figure 
1.1) (83, 88). The life cycle of B. burgdorferi depends on horizontal transmission, 
meaning that the larval and nymphal tick must share a host. As such, during late spring or 
early summer rodents are infected with B. burgdorferi by infected nymphs, and in the late 
summer, larvae acquire B. burgdorferi from the infected rodents. Adult I. scapularis feed 
on large mammals during the fall, in particular, the white-tailed deer, and then lay eggs, 
which persist through the winter and spring and hatch the following summer (Figure 1.1) 
(136). Although the white-tailed deer is not directly involved in the enzootic life cycle of 
B. burgdorferi, it is required for survival of I. scapularis (136). Humans are not involved 
in the maintenance of B. burgdorferi in the wild, and thus are not part of the enzootic life 
cycle of the spirochete. Instead, humans are an incidental host, which acquire the 
infection from infected ticks questing for their next blood meal. Most human infections 
occur during late spring or early summer, which is coincedent with the nymphal feeding 
period.  
 3 
The vector ecology of B. burgdorferi and genospecies is regional. For example, in 
the Western United States, two intersecting enzootic cycles are required for human 
infection with B. burgdorferi. One cycle, involving the dusky-footed wood rat and I. 
spinipalpis ticks, which do not bite humans, maintain the B. burgdorferi in nature. The 
other cycle, involves dusky-footed wood rats and I. pacificus ticks, which are less often 
infected, but which do bite humans (23). In the southeastern United States, nymphal I. 
scapularis ticks feed primarily on infection-resistant lizards, and as a consequence, the 
prevalance of B. burgdorferi in nature is low, along with the incidence of human 
infection (77). In Europe, B. burgdorferi sensu lato is maintained in nature by I. ricinus; 
however, the preferred host of these ticks is being debated because they feed on more 
than 300 animal species (50). In Asia, the enzootic life cycle of Borrelia species involve 
larval and nymphal I. persulcatus ticks, which feed on voles, shrews and birds and adult 
ticks, which feed on larger animals (72).  
The biology of B. burgdorferi  
The B. burgdorferi (strain B31) genome has been completely sequenced. It has a 
single linear chromosome of around one megabase and 21 plasmids, many of which are 
indispensable (44). B. burgdorferi does not possess LPS-encoding genes (44) or any 
recognizable toxins, despite the ability of this microorganism to cause human disease. In 
addition, B. burgdorferi express very few proteins with recognizable biosynthetic 
activity, and therefore, the organism depends on the host for most of its nutritional 
requirements.  
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Borrelia burgdorferi is approximately 0.2 to 0.3 µm by 20 to 30 µm, and is a 
vigorously motile bacterium due to the presence of periplasmic flagella, which run 
lengthwise between the peptidoglycan layer and the outer membrane. Flagella originate at 
the ends of the spirochete where they are anchored to the cytoplasmic membrane and 
wind around the protoplasmic cylinder (Figure 1.2B) (49). The presence of flagella also 
gives B. burgdorferi its distinctive corkscrew shaped morphology and may be important 
in the invasiveness of the spirochete into target tissues and organs (Figure 1.2A).  
One of the most striking features of the Borrelia genome is the large number of 
open reading frames (ORF's) encoding lipoproteins (44), including outer-surface 
lipoproteins (Osp's) A through F and VLsE, an important lipoprotein that undergoes 
antigenic variation and is involved in immune evasion (144). Five percent of the 
chromosomal ORF's encode putative lipoproteins, whereas 14.5% to 17% of the 
functionally complete ORFs contained in these B. burgdorferi plasmids encode 
lipoproteins (44). Lipoproteins are distributed throughout the outer leaflet of the inner-
membrane (cytoplasmic membrane) and both the inner and the outer leaflets ouf the 
outer-membrane. The abundant lipoprotein coding potential of B. burgdorferi suggests 
that lipoproteins may be important for the survival of the spirochete. During tick feeding, 
as a result of increased temperature and nutrient availability, as well as reduced pH, 
expression of several B. burgdorferi lipoproteins is augmented (3).  
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Transmission of B. burgdorferi into the human host 
The Ixodid tick, unlike any other hematophagous arthropod vector, engorges for 4 
to 8 days on the vertebrate host in order to feed to repletion (123). Transmission of B. 
burgdorferi into the human host requires between 40 and 48 hours following I. scapularis 
attachment. During the acquisition of the bloodmeal, B. burgdorferi differentially 
regulates several genes that enable the passage from the midgut through the hemolymph 
and into the salivary glands (3). For instance, the lipoprotein OspA is expressed at high 
levels in the gut of the unfed tick, but is downregulated upon tick feeding, while the 
expression of OspC increases 90 fold (128). OspA is involved in the attachment of B. 
burgdorferi to the midgut of the tick through its interaction with the tick receptor 
TROSPA, which protects the spirochete from the digestive and defense pathways of the 
tick (105-107). Thus, downmodulation of OspA facilitates the transmission of the 
spirochete into the human host (106). Furthermore, upregulation of OspC is required for 
the survival of the spirochete in the human host during the initial phase of infection (54, 
108), although its exact role both in the tick and the mammalian host remains unclear (54, 
108). 
The first barrier B. burgdorferi encounters during its colonization of the human 
host is serum complement, which occurs during its deposition into the dermis. 
Complement is a collection of serum proteins and cell surface receptors that are involved 
in the early response to pathogens, including B. burgdorferi  (80). Destruction of 
microorganisms via complement involves the formation of a pore in the microbial cell 
membrane by the membrane attack complex (MAC), which results in the lysis of the 
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organism. Three different pathways elicit complement activation: the classical (antigen 
antibody-mediated), lectin and alternative (pathogen surface) pathway. These pathways 
converge at the level of C3 convertase, a protease that cleaves complement component 
C3 into C3a and C3b. As a result, C3b can 1) bind to the surface of the bacteria and 
facilitate internalization of the spirochete via opsonization or 2) bind C3 convertase and 
facilitate the deposition of downstream components onto the bacterial surface resulting in 
the formation of the MAC and lysis of the cell. 
B. burgdorferi activates the classical and alternative pathways of the complement 
cascade (69). The activation of complement has been associated with decreases in 
spirochetal numbers in different tissues of infected mice (80), indicating the importance 
of the complement system early in B. burgdorferi infection. The members of the B. 
burgdorferi sensu lato group, which includes B. burgdorferi sensu stricto, B. garinii and 
B. afzelii, have evolved a variety of mechanisms enabling them to escape complement-
mediated lysis, including the expression of complement regulator-acquiring surface 
proteins (CRASPs) and OspE-related proteins (ERPs), which serve as binding sites for 
the complement inhibitor factor H and factor H-like protein 1 (FHL-1) (59, 73, 74) The 
interacti0on of factor H with these proteins recruits a protease (factor I) that cleaves and 
inactivates the complement serum proteins, C3b and C4b. Cleavage of these two 
complement proteins prevents the deposition of downstream components onto the surface 
of the spirochete; thereby, halting the formation of the membrane attack complex. B. 
burgdorferi also express a CD59-like molecule on the outer membrane, which can 
inactivate MAC and prevent complement-mediated lysis (109). It has been speculated 
that most borreliae are able to evade complement-mediated lysis, and recently a novel 
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protein expressed by B. hermsii (a relapsing fever spirochete) has been discovered which 
affords protection to spirochete by inactivating C3b (61). However, iC3b serves as a 
ligand for the complement receptor CR3, which mediates the internalization of iC3b-
opsonized pathogens. Thus, although the expression of CRASP-1 could circumvent 
MAC-mediated killing, it could also generate iC3b in close proximity to the spirochete 
resulting in CR3-mediated uptake and subsequent phagocytic destruction. The relative 
contribution between these two modes of complement-mediated killing during Lyme 
pathogenesis is not clear. Because B. burgdorferi express CRASPs, we hypothesize that 
CR3-mediated uptake of iC3b opsonized spirochetes would represent an important 
mechanism of bacterial clearance, especially during the initial deposition of the bacterium 
in the skin, which occurs during the bloodmeal and also during the dissemination of the 
spirochete through the mammalian circulation. Moreover, 
During the acquisition of the blood meal and transmission of the spirochete, the 
tick hypostome punctures the host dermis activating the host's hemostatic and innate 
immune defenses resulting the recruitment of innate immune cells including neutrophils 
and macrophages, among other cell types (135). One way B. burgdorferi overcomes this 
cellular challenge is by usurping tick salivary proteins that are potent suppressors of the 
host defense mechanisms, including neutrophil, macrophage, B cell and T cell activation 
(4, 38, 51, 57, 70, 71, 78, 111, 112, 131-133).  
Lyme disease pathogenesis 
Following deposition into the dermis and successful colonization, the highly 
motile B. burgdorferi establishes local infection (Stage I, Lyme disease). This is marked 
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by the appearance of a slowly expanding skin lesion called erythema migrans (EM), 
which forms at the site of the tick bite 70 to 80 percent of the time and may take between 
3 and 32 days to appear (122, 126). In the United States, other symptoms that may appear 
at this stage include fever, headache, malaise, myalgia and/or arthralgia and clinical signs 
that suggest spirochete dissemination (125).  
The spirochete then disseminates throughout the body by binding to blood 
components, including plasminogen and its activators, activated platelets and integrins 
lining the endothelium of blood vessels (Stage II, Lyme disease) (30-32). Symptoms of 
stage II can include conduction system abnormalities, meningitis, and acute arthritis, 
which appear in 60% of untreated individuals in the United States (124). Some untreated 
individuals develop stage III Lyme disease, which is generally characterized by 
prolonged infection with the spirochete. Late stage symptoms may include chronic 
arthritis, neuroborreliosis, or cutaneous lesions such as acrodermatitis chronica 
atrophicans.  
 Clinical presentations of Lyme disease are the result of local inflammatory 
reactions to the spirochete. Consequently, B. burgdorferi is the subject of intensive 
investigation in order to elucidate the mechanisms that contribute to its ability to cause 
persistent infection and multi-system disease, despite the development of strong immune 
responses. The control of the number of bacteria in the mammalian host likely depends 
on several immune effector mechanisms, such as the development of antibody responses 
and the capacity of phagocytic cells to clear spirochetes.   
Murine models of Lyme disease 
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Among the inflammatory conditions observed in infected humans, Lyme arthritis 
and carditis are reproduced to some extent in the murine model of infection with the 
spirochete (7). Mice become persistently infected upon experimental infection and 
develop joint and cardiac inflammation that resembles the human disease (6). The 
incidence and severity of murine Lyme borreliosis is dependent on the genetic 
background of the infected animals. Thus, C3H mice develop Lyme carditis and arthritis 
with a greater incidence and severity than strains such as DBA/2, B6 or 129 (6, 22, 141). 
As a result, we prefer to use the B6 model of B. burgdorferi infection, because the 
modulatory affects of specific cell types are not constrained by the high degree of 
inflammation observed in highly susceptible mouse strains, such as C3H. The basis for 
the genetic susceptibility to the development of Lyme inflammation is unknown. Among 
the differences among diverse inbred strains of mice, a notable factor that can influence 
the response to infection and the outcome of infectious inflammation is the capacity of 
iNKT cells to respond to specific ligands. Thus, recent reports have demonstrated that 
iNKT cells from B6 mice respond more vigorously and with faster kinetics than those 
from other strains, including BALB/c and C3H (116). These results make B6 mice an 
ideal model to test the response of iNKT cells in the context of murine infection. 
T cell activation during experimental Lyme borreliosis 
 The T cell-derived cytokine, IFNγ, has been shown to enhance cellular responses 
to various pathogens, most notably intracellular pathogens, including viruses, bacteria 
and parasites. Reports have suggested that an intact IFNγ response is important for 
controlling the pathogenesis of Lyme carditis but not Lyme arthritis (16, 20, 22, 52). This 
is an interesting observation given that B. burgdorferi is an extracellular spirochete. 
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Although the presence of T cells in the absence of B cells results in the exacerbation of 
Lyme carditis (94), mice lacking T cells failed to resolve cardiac inflammation at 60 days 
of infection (93) and CD4+ T cells have been shown to mediate the regression of murine 
Lyme carditis 45 days after infection (16). The contribution of invariant NKT cells to 
these responses has until now not been determined.  
Invariant Natural Killer T cell activation 
 Natural Killer T (NKT) cells are a unique and complex population of T 
lymphocytes that co-express αβ T cell (TCR) and NK receptors (53, 75). In humans, 
NKT cells nearly always have a Vα24-Jα18 TCR (75), whereas mouse NKT cells 
possess a Vα14-Jα18 rearrangement. In both humans and mice, this invariant TCR is 
capable of antigen recognition in the context of an MHC class I-like molecule, CD1d, 
which is adapted for the presentation of lipid antigens (130). Experimental infection of 
B6/129 mice deficient in CD1d with B. burgdorferi revealed that CD1d has an important 
role in controlling spirochete burdens as well as Lyme arthritis (76). Although CD1d-
deficient mice lack Vα14-Jα18i NKT cells because of a developmental failure in the 
thymus, they also lack other CD1d-reactive T cells with more diverse TCRs (26, 27, 76) 
and further show deficient marginal zone B cell responses, which are involved in the 
response to B. burgdorferi (10, 11). This pleiotropy complicates the assignment of the 
observed phenotype to a single cell type, such as iNKT cells. In contrast, Jα18-deficent 
mice specifically lack Vα14-Jα18i NKT cells and thus represent a suitable model to 
determine the role of iNKT cells in the pathogenesis of Lyme disease. Upon activation, 
Vα14-Jα18i NKT cells rapidly produce large quantities of cytokines such as IFNγ, IL-4, 
IL-17, IL-5 and IL-13, which can modulate many immunological processes, including 
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tumor immunity, maintenance of self-tolerance, prevention of autoimmune disorders and 
protection from a variety of pathogens during experimental infections (75, 96). 
Pathogenic bacteria can also activate Vα14-Jα18i NKT cells indirectly through Toll-like 
receptor (TLR) 4, 7 or 9-driven maturation of dendritic cells, which then present self-
glycolipids in the context of CD1d and soluble factors such as IL-12 or type 1 interferon 
(19, 92). Until recently, the identification of an iNKT cell antigen expressed by a human 
pathogen capable of directly activating iNKT cells eluded investigators. Kinjo and co-
workers reported that the Lyme disease spirochete Borrelia burgdorferi expresses a 
diacylglycerol glycolipid, BbGL-IIc, which acts as a natural antigen for murine and 
human iNKT cells (68). To date B. burgdorferi is the only known human pathogen 
containing an antigen capable of activating iNKT cells. 
Antibody responses during Lyme borreliosis 
 Prior to the development of an antibody-specific immune response, the degree of 
clearance by circulating phagocytes is very limited, indicating that the humoral response 
to B. burgdorferi might be necessary for resolution of spirochetal infection.  Plasma cells 
are the principal effector cells involved in the humoral response, and antibodies are 
specific and powerful effector molecules of the adaptive immune response. Once 
antibodies bind to their specific foreign antigen, they confer protection to the host using a 
variety of effector mechanisms. In general, antibodies contribute to adaptive immunity by 
neutralizing microbes or their products, activation of complement, and opsonization, 
which leads to phagocytosis of microorganisms. The activation of B cells and their 
differentiation into antibody secreting plasma cells often requires an interaction with 
helper T cells, which controls isotype switching as well as somatic hypermutation. 
 12 
However, in response to B. burgdorferi, T cell independent humoral responses also 
confer protection to the host. T cell independent humoral immune responses are critical 
for resolving symptoms associated with B. burgdorferi infection (93). T cell deficient 
mice infected with B. burgdorferi mount a protective antibody response, which upon 
passive serum transfer affords protection to severe combined immune deficient (SCID) 
mice from homologous challenge (93, 118). However, mice that lack both B and T cells 
developed severe arthritis and carditis in response to infection with B. burgdorferi (94). 
 Stimulation of CD40L, which interacts with CD40 on T cells, is crucial for T cell 
dependent activation of B cells and subsequent antibody production. Mice deficient for 
CD40L are also able to generate protective antibody responses against B. burgdorferi and 
therefore resolve infection (43). Additionally, Class II MHC deficient mice are able to 
resolve symptoms associated with B. burgdorferi infection (42). Thus, it is implied that 
B. burgdorferi antigens have the ability to stimulate B cells, to expand clonally, and to 
differentiate into antibody producing plasma cells, and that T cell independent humoral 
responses are extremely important for the protective immunity against B. burgdorferi. 
The importance of antibodies in controlling B. burgdorferi infection was 
underscored by the discovery of complement-independent bactericidal antibodies, which 
have the capacity to control an infection. An IgG1k monoclonal antibody termed CB2 
binds to B. burgdorferi-OspB via a single lysine residue causing an alteration in the 
structure of OspB; thereby, increasing its susceptibility to protease degradation, and 
ultimately leading to the lysis of the spirochete (41). Another bactericidal antibody, 
H6831, with identical specificity to OspB was reported. Both CB2 and H6831 are so 
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effective at killing B. burgdorferi that their selective pressure on the growth of B. 
burgdorferi was used to generate escape mutants of B. burgdorferi that lacked the lysine 
necessary for antibody binding to OspB, which made the escape mutants less infectious 
(34).
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Table 1.1. Pathogenic versus non-pathogenic B. burgdorferi and their respective tick 
vectors and geographic distribution. 
 B. burgdorferi sensu lato is comprised of the three genospecies of B. burgdorferi 
that cause human Lyme disease. In addition to these, eight species of Borrelia have been 
identified which are non- or minimally pathogenic. B. burgdorferi  sensu stricto is the 
causative agent of Lyme disease in North America. 
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Figure 1.1. Feeding periods of Ixodes scapularis during the immature and adult 
stages of its life. 
 Larval I. scapularis ticks feed during the late summer and then molt into a 
nymphal tick, which feeds the following year during late spring or early summer. Larval 
and nymphal I. scapularis ticks feed on certain rodents, including the white-footed mouse 
and chipmunk. During late spring or early summer rodents are infected with B. 
burgdorferi by infected nymphs, and in the late summer, larvae acquire B. burgdorferi 
from the infected rodents. Adult I. scapularis feed on large mammals during the fall, and 
in particular, the white-tailed deer, and then lay eggs which persist through the winter and 
spring and hatch the following summer. Although the white-tailed deer is not directly 
involved in the enzootic life cycle of B. burgdorferi, it is required for survival of I. 
scapularis. 
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Figure 1.2. The morphological characteristics and structure of B. burgdorferi. 
(A) Borrelia burgdorferi is approximately 0.2 to 0.3 µm by 20 to 30 µm, and (B) 
is a vigorously motile bacterium due to the presence of periplasmic flagella, which run 
lengthwise between the peptidoglycan layer and the outer membrane and originate from 
either end of the spirochete where they are anchored to the cytoplasmic membrane and 
wind around the protoplasmic cylinder. The presence of flagella also gives B. burgdorferi 
its distinctive corkscrew shaped morphology and may be important in the invasiveness of 
the spirochete into target tissues and organs. 
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Materials and Methods 
Mice and infection with B. burgdorferi 
Jα18-deficient mice (36) were bred at UMass Amherst. The mice have been 
backcrossed to the C57Bl/6 (B6) background more than 10 generations. Age-matched B6 
mice were purchased from Jackson laboratories. IFNγRα-deficient mice in a 129 Sv/J 
background were purchased from Jackson laboratories and bred at UMass Amherst.  Six 
to 8 week old mice were infected by subcutaneous injection with 105 B. burgdorferi 
strain 297 in the midline of the back, as previously described (58). At 2 weeks of 
infection, which represents the acute phase of disease, the mice were sacrificed and 
analyzed for inflammation and bacterial burdens, as previously described (100). Arthritis 
and carditis were evaluated histologically in formalin-fixed sections processed for H&E 
staining. The joints were also decalcified. The hearts were cut in half through bisections 
across the atria and ventricles prior to sectioning. Signs of arthritis were evaluated as 
described (100), based on a combined assessment of histological parameters of B. 
burgdorferi-induced inflammation, such as exudation of fibrin and inflammatory cells 
into the joints, alteration in the thickness of tendons or ligament sheaths, as well as 
hypertrophy and hyperplasia of the synovium.  Signs of carditis were evaluated based on 
the cardiac inflammatory infiltrate, including the infiltration of connective tissue with 
macrophages at the base of the heart, including surrounding the aortic valve and the atria.  
Carditis was scored on a scale of 0 (no inflammation), 1 (mild inflammation with less 
than two small foci of infiltration), 2 (moderate inflammation with 2 or more foci of 
infiltration), or 3 (severe inflammation with focal and diffuse infiltration covering a large 
area).  Both joint and heart tissue sections were blindly examined. The Institutional 
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Animal Care and Use Committee at UMass Amherst approved all procedures involving 
animals. 
Cells and stimulations 
Mouse bone marrow cells were collected from the femoral shafts by flushing 3 
times with 1 ml of cold RPMI (10% FCS and 1% penicillin/streptomycin) supplemented 
with 20% L929-conditioned RPMI. The cell suspensions were cultured in 100mm x 
15mm petri dishes (Fisher Scientific) in 20% L929-conditioned RPMI for 8 days at 37º C 
with 5% CO2. Following incubation, non-adherent cells were eliminated and adherent 
macrophages scraped, counted and resuspended in serum-free RPMI medium without 
antibiotics prior to use. RAW264.7 macrophages were cultured in RPMI but washed and 
resuspended in serum- and antibiotic-free RPMI before use. 106 BMMs or RAW264.7 
cells per ml were incubated with recombinant murine IFNγ (rmIFNγ; carrier- and 
endotoxin-free; eBioscience, Inc., San Diego, CA) (0, 0.5, 5, 50 ng ml-1) for 12h and 
analyzed for expression of CD1d (PE-anti-mouse CD1d, eBioscience, Inc.) or  stimulated 
with live B. burgdorferi (strain 297) at a 25:1 multiplicity of infection (m.o.i) for 12h. 
Following stimulation with B. burgdorferi, culture supernatants were analyzed by ELISA 
for TNFα and IL-6, as previously described (103). 
B. burgdorferi-specific antibodies 
Analysis of total IgG and IgM were determined by coating 96 well plates with 0.5 
µg/ml (IgG) or 1.0 µg/ml (IgM) of a B. burgdorferi strain 297 lysate and incubated with 
serial two-fold dilutions starting at 1:100 followed by incubation with HRP-conjugated 
anti mouse IgM or IgG (BD Pharmingen) (1:10000 dilution). The reactions were 
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developed using 1-component TMB substrate and stopped with TMB stop solution (KPL, 
Inc., Gaithersburg, MD). 
Quantitative analysis of IFNγ  expression 
The relative expression of IFNγ in cardiac tissue was determined using total RNA 
extracted from the base of the heart using the TRIzol reagent (Invitrogen, Carlsbad, CA) 
according to the manufacturer's instructions. The RNA was treated with DNase I 
(Promega, Madison, WI), and reverse transcribed using random primers (Invitrogen) and 
SuperScript II reverse transcriptase (RT) (Invitrogen). The cDNA was amplified using 
primers specific for glyceraldehyde 3-phosphate dehydrogenase (gadph; 5’-CCA TCA 
CCA TCT TCC AGG AGC GAG-3’ and 5’-CAC AGT CTT CTG GGT GGC AGT GAT 
-3’) and ifnγ ( (5’-GCG TCA TTG AAT CAC ACC-3’ and 5’-GGA CCT GTG GGT 
TGT TGA CC-3’) in an Mx3005P® QPCR System (Stratagene, La Jolla, CA) and SYBR 
green-containing reaction buffer (Roche, Nutley, NJ). Relative expression of the gene is 
referred to control-infected mouse heart tissue, as described (65). 
Detection of invariant NKT cells 
DNA from the hearts of control and infected mice were utilized to perform a 
nested-PCR reaction using primers specific for the Vα14-Jα18i TCR. For the first 
reaction, non-specific TCR (5'-GTC CTC AGT CCC TGG TTG TC-3' and 5'-CTG CCT 
CCG AGG TAG TGA C-3') was amplified using 5 µl of DNA in a total volume of 50 µl 
with the following conditions: 94ºC 2 min, (94ºC 1 min, 55ºC 1.5 min, 72ºC 1.5 min) x 
30 and 72ºC 2 min. A second reaction using primers specific for the Vα14-Jα18i TCR 
(5'-GAC AGT CCT GGT TGA CC-3' and 5'-AAT GCA GCC TCC CTA AG-3’) was 
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performed using 5 µl of template from reaction 1 with the same conditions, except that 35 
cycles were used. 
Confocal Microscopy 
At sacrifice, hearts were collected and snap-frozen in O.C.T. freezing medium 
(Sigma) and stored at -80ºC. Hearts were grossly cut through the ventricles parallel to the 
atria, sectioned using a Triangle Biomedical Sciences Cryostat (Durham, NC) and every 
sixth 10 micron section through the aortic sinus was placed on Fisherbrand Superfrost 
microscope slides (Fisher Scientific, Pittsburgh, PA). Sections were fixed in -20 ºC 
acetone for 5 min, rehydrated in distilled water for 3 min, blocked with Fc Block (anti-
mouse CD16/32, clone 2.4G2; BD Pharmingen, Franklin Lakes, NJ) and stained with the 
following monoclonal antibodies: Alexa Fluor488 anti-mouse CD3 (clone 145-2C11), 
Alexa Fluor647 anti-mouse CD11b (clone M1/70), PE-anti-mouse CD1d (clone 1B1; BD 
Pharmingen). Nuclear staining was done with DAPI (Roche). The sections were imaged 
using a Zeiss LSM 510 META confocal laser scanning microscope (Zeiss Microimaging, 
Thornwood NY) operating in the multitrack mode, as described before (62). 
Analysis of phagocytosis 
 BMM or RAW264.7 cells were activated with different doses of rmIFNγ for 12 
hour in serum- and antibiotic-free RPMI prior to the addition of GFP-expressing B. 
burgdorferi strain 297 at an m.o.i. of 10 for 4h. To distinguish between binding and 
internalization of spirochetes, the mixtures were incubated at 4 °C and 37 °C, in parallel. 
The incubation at 4 °C results in the binding of particles, but not their internalization 
(15). After the incubation, the cells were washed and analyzed by flow cytometry. For 
Apotome epifluorescence analysis of phagocytosis, RAW264.7 cells were activated with 
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50 ng ml-1 of rmIFNγ and challenged with GFP-B. burgdorferi at 37º C, as described. The 
cells were then washed, cytospun and stained with the macrophage cell membrane 
marker F4/80 (clone BM8; rat anti-mouse F4/80, eBioscience, Inc.) followed by a 
secondary stain with Alexa Fluor594 goat anti-rat IgG (Invitrogen). 
Statistical analysis 
 The results are presented as means ± SE. Significant differences between means 
were calculated with the Student’s t test. P values of 0.05 or less were considered 
statistically significant. 
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Results and Discussion 
Vα14-Jα18i NKT cells modulate the pathogenesis of Lyme carditis  
The identification of B. burgdorferi-derived diacylglycerol glycolipids as natural 
antigens to Vα14- and Vα24i- NKT cells (68), prompted us to examine the role of Vα14-
Jα18i NKT cells in the pathogenesis of Lyme disease. To determine whether Vα14-Jα18i 
NKT cells contribute to the host response to B. burgdorferi, we syringe-infected wild 
type and Jα18-deficient C57Bl/6 mice with 105 spirochetes in the midline of the back and 
allowed infection to progress for 2-3 weeks, which represents the acute phase of infection 
(100). Histological evaluation of the joints and hearts of the infected mice revealed that 
Jα18-deficient animals are more susceptible to both arthritis (Figure 1.3A) and carditis 
(Figures 1.3B and C). Although there was a trend towards worse arthritis in mice that 
lacked Jα18, the difference was not significant (Student t test; p = 0.07; n = 15). In 
contrast, carditis severity in Jα18-deficient mice was significantly increased (p < 0.01). 
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Figure 1.3. Jα18-deficiency results in increased carditis during infection with B. 
burgdorferi.  
 
Joint (A) and cardiac (B) inflammation in wild type and Jα18-deficient mice 2 
weeks following syringe infection with B. burgdorferi. Data are representative of 2 to 3 
experiments with 5 mice per group. (C) Representative H&E-stained cardiac sections 
from uninfected, and infected wild type and Jα18-deficient mice. 
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Infection of Jα18-deficient mice results in increased spirochetal burdens in the 
heart 
Inflammation during experimental infection with B. burgdorferi is dependent on 
the ability of the spirochete to persist in cardiac and joint tissue (141). Thus, we evaluated 
the ability of the mice to clear B. burgdorferi in the absence of Vα14-Jα18i NKT cells by 
assessing bacterial loads in the heart tissue of the infected animals, where the differences 
in inflammation are more evident as a result of the absence of iNKT cells. Compared to 
wild type mice, Jα18-deficient mice harbored more B. burgdorferi in their heart, while 
the bacterial burden in the ear was unaffected by the loss of Vα14-Jα18i NKT cells 
(Figure 1.4). Vα14-Jα18i NKT cells have been shown to potentiate the antibody response 
to various pathogens (46, 79). Since the antibody response to B. burgdorferi is critical to 
clear spirochetal infection (34), we assessed the B. burgdorferi-specific IgM and IgG 
responses 2 weeks following infection. The sera levels of antigen-specific IgM and IgG 
in wild type and Jα18-deficient mice were similar (Figures 1.5A and B) as well as IgG 
antigen specificity as determined by Western blot (Figure 1.5C). 
Moreover, studies have demonstrated that iNKT cells can promote naïve CD4+ T 
cell (Th0) polarization towards a Th1 or Th2 effector phenotype, depending on the 
infectious agent (130). For example, iNKT cells enhance Chlamydia trachomatis 
infection through augmentation of the Th2 response (14). The mechanism behind iNKT-
directed T helper cell polarization has not been defined; however, it is intriguing to 
speculate that the early production of IFNγ by iNKT cells during infection with B. 
burgdorferi can promote differentiation of Th0 cells toward the Th1 phenotype by 
inducing IL-12 production. We therefore determined the contribution of iNKT cells to 
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Th1 differentiation during infection with B. burgdorferi. Restimulation of Jα18-deficient 
splenocytes, obtained from infected mice, with B. burgdorferi did not result in 
diminished levels of IFNγ, compared to wildtype controls (Figure 1.6).  
 These results demonstrate an important role for Vα14-Jα18i NKT cells in the 
control of B. burgdorferi at the tissue -rather than at the systemic- level where acute 
inflammation occur, and that the differences in B. burgdorferi control and pathology 
between the Jα18-deficient and wildtype mice are not due to distinct antibody responses 
or altered T cell polarization.
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Figure 1.4. Jα18-deficient mice harbor increased bacterial burdens in the hearts 
during B. burgdorferi infection. 
 
Quantitative real-time PCR determination of spirochete burden in the ears and 
heart of infected wild type (n=13 and n=8, respectively) and Jα18-deficient mice (n=14 
and n=5, respectively) 2 weeks following infection in 2 separate experiments.
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Figure 1.5. Jα18-deficient mice have a normal IgM and IgG response following B. 
burgdorferi infection.  
 
 Serum ELISA titers for total IgM (A) or IgG (B) from 2-week infected wild type 
and Jα18-deficient mice. Results depicted were derived from 2 uninfected mice and 7-15 
mice per infected group and are representative of at least 2 independent experiments. (C) 
Immunoblot for total IgG from wildtype and Ja18-deficient mice 2-weeks post infection 
with B. burgdorferi. Numbers correspond to individual mice. 
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Figure 1.6. Vα14-Jα18i NKT cell-derived IFNγ  does not impair normal Th1 
polarization during infection with B. burgdorferi. 
 
ELISA analysis of IFNγ following B. burgdorferi-specific restimulation of whole 
splenocytes obtained from wildtype or Jα18-deficient mice. Results depicted were 
derived from 3 wildtype mice and 7 Jα18-deficient mice per group. 
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Vα14-Jα18i NKT cells and CD1d-positive macrophages migrate to the inflamed 
heart of B. burgdorferi-infected mice 
 
Vα14-Jα18i NKT cells have been shown to migrate to sites of inflammation in 
the lung, liver and spleen (1, 86, 95, 101). We therefore analyzed the presence of Vα14-
Jα18i NKT cells in the hearts of uninfected and B. burgdorferi-infected mice using a 
nested PCR approach (37, 117). While control mice did not harbor Vα14-Jα18i NKT 
cells in the heart, the presence of the invariant TCR alpha chain was readily detected in 
the inflamed cardiac tissue of wild type, but not Jα18-deficient mice (Figure 1.7A). We 
also analyzed by confocal microscopy the hearts of the infected mice for the presence of 
CD1d, as a potential contributor to the activation of iNKT cells. The infected hearts 
contained, as expected, CD11b-and CD3-expressing lymphocytes, (Figure 1.7B), and 
confirmed (115) a predominant macrophage infiltration during Lyme carditis. The 
inflamed hearts also showed increased expression of CD1d compared to uninfected 
controls (Figure 1.7B). Because CD1d expression is a requirement of APC-mediated 
activation of iNKT cells, we determined the identity of the iNKT cell activator in the 
inflamed heart. Confocal analysis revealed that CD1d expression colocalized with CD11b 
expression (Figure 1.7C). The presence of CD1d in the inflamed hearts indicates the 
potential for the direct activation of Vα14-Jα18i NKT cells through presentation of B. 
burgdorferi glycolipids. Taken together, the appearance of iNKT cells in a B. burgdorferi 
colonized organ competent in iNKT antigen presentation, which presents with 
exacerbated disease and increased bacterial burden in the absence of iNKT cells, is 
indicative of an important role for this cell type in protection against murine Lyme 
carditis. 
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Figure 1.7. Vα14-Jα18i NKT cells and CD1d positive macrophages migrate to the 
inflamed heart during infection with B. burgdorferi.  
 
(A) Nested PCR was used to detect the presence of the Vα14-Jα18i TCR in the inflamed 
heart of wild-type infected mice. gapdh amplification was used to verify the presence of 
DNA. The data are derived from 2 control mice and 3 mice per infected group. (B) 
Confocal microscopy analysis of heart sections of control or infected B6 mice to 
determine the presence of CD1d+ (red), CD11b+ (purple) and CD3+ cells (green). Nuclei 
were stained with DAPI. Results depicted here are representative of 2 experiments. (C) 
Confocal microscopy of a B. burgdorferi-infected heart showing the presence of CD11b+ 
(green) cells and their co-localization with CD1d (red) staining. The panel on the right 
shows co-localization of both signals. 
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Vα14-Jα18 iNKT cells are responsible for the production of IFNγ  in the infected 
heart 
 
B. burgdorferi glycolipid-pulsed dendritic cells induce IFNγ production by Vα14-
Jα18i NKT cells in vivo (68). In addition, IFNγ-producing CD4+ T cells facilitate the 
regression of murine Lyme carditis (16), while Stat1-deficient mice infected with B. 
burgdorferi develop exacerbated Lyme carditis, compared to control mice (20). We 
therefore addressed the contribution of Vα14-Jα18i NKT cells to the pool of cardiac 
IFNγ in B. burgdorferi-infected mice.  B. burgdorferi infection of wild type mice resulted 
in increased expression of the ifnγ gene in the cardiac tissue compared to uninfected 
controls, as determined by quantitative RT-PCR (Figure 1.8). However, the level of ifnγ  
gene expression in the hearts of B. burgdorferi-infected mice was reduced in Jα18-
deficient mice at the peak of disease (Student’s t test, p < .05; Figure 1.8). These results 
indicate that Vα14-Jα18i NKT cells are critical for generating an IFNγ response in the 
heart, which might play a role in the pathogenesis of Lyme carditis. 
We next tested the direct contribution of IFNγ to the pathogenesis of Lyme 
carditis by infecting IFNγ  receptor alpha (IFNγRα)-deficient 129S mice. Like Jα18-
deficient mice, IFNγRα-deficient mice developed increased cardiac inflammation 
following syringe infection with B. burgdorferi  (Student t test; p < .05; Figure 1.9A), 
supporting a role for IFNγ in the protection against Lyme carditis. The quantification of 
B. burgdorferi burdens by real-time PCR in the heart of the infected mice showed a 
significant (p < .006) increase in the levels of bacteria in the absence of IFNγ-mediated 
signals (Figure 1.9B), indicating that IFNγ contributes to the control of bacterial burdens 
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during infection. Overall, these data indicate that Vα14-Jα18i NKT-derived IFNγ 
mediates protection against cardiac inflammation during infection with B. burgdorferi. 
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Figure 1.8. Vα14-Jα18i NKT cells regulate the expression of IFNγ  in B. burgdorferi-
infected hearts.  
Relative IFNγ mRNA expression in the heart by real-time RT-PCR. Hearts were 
removed from 2-week B. burgdorferi-infected wildtype or Jα18-deficient C57Bl/6 mice. 
Results are the average of 3 mice per group.
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Figure 1.9. IFNγ  mediates protection against Lyme carditis and facilitates clearance 
of B. burgdorferi from the heart. 
(A) Increased cardiac inflammation in IFNγRα-deficient mice at 2 weeks of 
infection with B. burgdorferi, compared to wild type mice. Results are derived from 2 
independent experiments. (B) Bacterial burdens in the heart of wild type (n=5) and 
IFNγRα-deficient, infected mice at 2 weeks of infection. * Student’s T test, p<0.006.
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IFNγ  signaling enhances macrophage responses to B. burgdorferi 
The mechanism underlying the control of cardiac inflammation during murine 
Lyme borreliosis by IFNγ has not been elucidated. IFNγ enhances cellular responses, 
including macrophages, to various pathogens (17). Indeed, activation of bone marrow-
derived macrophages (BMMs) with IFNγ enhances spirochete recognition, as evidenced 
by augmented TNFα and IL-6 production elicited against live B. burgdorferi (Figures 
1.10A and B). Increased B. burgdorferi burdens in the heart of IFNγRα-deficient and 
Jα18-deficient mice during the presence of a strong antibody response suggested a defect 
in phagocytic clearance of the spirochete by infiltrating macrophages. We therefore 
defined the contribution of IFNγ to macrophage-mediated clearance of B. burgdorferi by 
phagocytosis. First, we determined by flow cytometric analysis that BMMs readily 
phagocytose GFP-expressing infectious B. burgdorferi (Figure 1.10C).  Activation with 
recombinant murine IFNγ increased the already high phagocytic capacity of BMMs for B. 
burgdorferi (Figure 1.10C). We also performed this assay using the macrophage cell line 
RAW264.7. Incubation of RAW264.7 cells with GFP-B. burgdorferi resulted in a modest 
amount of phagocytosis, compared to BMMs, confirming previous reports indicating 
their relatively low phagocytic capacity (39). The activation of these cells with IFNγ 
markedly enhanced the percentage of cells that had internalized GFP-expressing B. 
burgdorferi, as determined by flow cytometric analysis and flourescence microscopy 
(Figures 1.10D and E). These results suggested that iNKT cells control the levels of 
spirochetes in the infected heart through the production of IFNγ and increased 
phagocytosis. 
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Figure 1.10. IFNγ  enhances the effector function of macrophages responding to B. 
burgdorferi. 
 
(A) rmIFNγ activation (0, 0.5, 5, 50 ng/ml) of BMMs for 16 h leads to enhanced 
production of TNFα (A) and IL-6 (B) in response to live B. burgdorferi. (C) BMMs were 
stimulated with (green histogram) or without (black histogram) 50 ng/ml of rmIFNγ for 
16 h. The cells were washed and assessed their phagocytic capacity for GFP-B. 
burgdorferi at an m.o.i of 25:1. (D) RAW264.7 cells were stimulated with 50 ng/ml of 
rmIFNγ for 16 h and assessed their phagocytic capacity, as before. (E) The cells were 
also cytospun in positively charged slides, stained for the macrophage surface marker 
F4/80 (red) and the nucleus (blue) and analyzed by fluorescence microscopy (ApoTome) 
for B. burgdorferi phagocytosis. Results are representative of at least 3 experiments. 
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IFNγ  enhances the surface expression of CD1d in macrophages 
 
Previous reports have suggested that IFNγ can increase CD1d surface expression 
by macrophages (75). We thus assessed the effect of IFNγ on the expression of CD1d in 
primary macrophages and RAW264.7 cells. We stimulated BMMs (Figure 2.9A) and 
RAW264.7 cells (Figure 1.11B) with 50 ng ml-1 of recombinant IFNγ for 16 h. The cells 
were subsequently assessed for surface CD1d expression by flow cytometry. IFNγ 
treatment increased the expression of CD1d in both BMMs and RAW264.7 cells (Figures 
1.11A and B). Since B. burgdorferi induces the upregulation of CD1 molecules on human 
monocytes (33), we also assessed the effect of live spirochetes on CD1d expression by 
BMMs and RAW264.7 cells.  In contrast to human monocytes, the stimulation of both 
BMMs and RAW264.7 cells with live B. burgdorferi resulted in a minimal increase of 
CD1d expression (data not shown). These results suggest that during infection with B. 
burgdorferi, Vα14-Jα18i NKT-derived IFNγ is self-renewing through its capacity to 
induce CD1d expression and presentation to Vα14-Jα18i NKT cells (Figure 1.12). 
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Figure 1.11. IFNγ  increases the surface expression of CD1d in macrophages. 
 BMMs (A) and RAW264.7 cells (B) were stimulated with 50 ng/ml of rmIFNγ 
for 16 h (red histogram) or left unstimulated (black histogram). The cells were washed 
and stained with an anti-CD1d antibody labeled with phycoerythrin (PE). The grey 
histogram represents unlabeled cells. Results are representative of at least 2 experiments 
for each cell type.
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Figure 1.12. Proposed model of iNKT cell activation in the heart during Lyme 
borreliosis. 
 Macrophages phagocytose invading B. burgdorferi and present antigen in the 
context of CD1d to local Vα14-Jα18 iNKT cells resulting in the production of IFNγ. 
IFNγ activation of macrophages results in enhanced phagocytosis of B. burgdorferi and 
upregulation of CD1d. These events further perpetuate iNKT cell activation and thus 
results in self-renewal of IFNγ. 
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CHAPTER II 
COMPLEMENT RECEPTOR 3 MEDIATES THE PHAGOCYTOSIS OF B. 
BURGDORFERI AND NEGATIVELY REGULATES PROINFLAMMATORY 
CYTOKINE INDUCTION 
Introduction 
The recognition of pathogenic bacteria or their constituents by pattern recognition 
receptors (PRRs) on the surface of innate immune cells is critical for the induction of an 
effective immune response. In addition to regulating cytokine secretion, nitric oxide 
production and cell maturation, engagement of these receptors can trigger phagocytosis 
of microbes and also orchestrate adaptive immunity. The Toll-like receptors (TLRs) 1 
and 2 function as PRRs for B. burgdorferi lipoproteins (2, 85), including the prototypical 
borrelial lipoprotein, OspA. Studies using the murine model of Lyme disease have shown 
that TLRs 1 and 2, as well as the TLR adaptor protein, MyD88, are important for 
controlling the expansion of B. burgdorferi in target organs and tissues (8, 18, 87, 137, 
138). Thus, it is well established that TLRs, their adaptor proteins or their co-receptors, 
such as CD14, are important in the recognition of B. burgdorferi (120, 138), but in 
regards to the identification of other PRRs involved in B. burgdorferi recognition, not 
much progress has been made. Moreover, although TLR signaling might control 
phagocytosis of B. burgdorferi to some extent (121), the identification of a bonafide 
receptor involved in spirochete phagocytosis has eluded investigators.  
Of particular interest are the β2 integrins, which include LFA-1 (CD11a/CD18), 
CR3 (CD11b/CD18) and CR4 (CD11c/CD18), because it was reported that reduced 
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expression of the common beta chain, CD18, results in exacerbated Lyme carditis during 
experimental infection with B. burgdorferi (55). Furthemore, CR3 and CR4 have been 
shown to participate in the recognition and phagocytosis of a number of pathogens, 
including Bacillus anthracis spores (102), Neisseria meningitidis (66), Bordetella 
pertussis (98) Francisella tularensis (12) and serum opsonized B. burgdorferi (29). The 
importance of β2 integrin-mediated immunoprotection is highlighted in patients suffering 
from leukocyte adhesion deficiency-1 (LAD-1) syndrome who suffer from severe 
symptoms, including defects in phagocytosis and recurrent infections. In these patients, 
mutations in CD18 result in little or no expression of LFA-1, CR3 or CR4 (60). 
In this study, we determine the role of CR3 in mediating phagocytosis of the 
Lyme disease spirochete B. burgdorferi and the production of proinflammatory 
cytokines.  
Innate immune responses to B. burgdorferi 
The recognition of pathogens or their constituents by cells of the innate immune 
system constitutes the ‘first line’ of host defense. The detection of conserved bacterial 
motifs, known as pathogen associated molecular patterns (PAMPs) initiates a cascade of 
responses that lead to the upregulation of chemokines and cytokines, adhesion molecules 
and a vast array of other effector molecules. These events are aimed at the recruitment of 
phagocytic cells, their activation and the eventual development of the adaptive immune 
response and depend on the presence of germline-encoded PRRs. These pattern 
recognition molecules are being extensively studied because they not only mediate the 
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initial response to microorganisms, but they also modulate the extent and quality of 
acquired immune response. Toll-like receptors (TLRs), identified as the mammalian 
counterparts of the Toll protein in Drosophila that mediates the immune response to 
fungi and Gram-positive bacteria are the most studied, but do not constitute the only 
mechanism by which innate immune cells recognize infecting microorganisms. C-type 
lectins, Scavenger receptors, integrins and Nod-like receptors are also PRR that are 
uniquely suited to recognize specific structures that are present in a group or groups of 
microorganisms and that distinguishes them from the more specific recognition of 
antigens by the T and B cell receptors. The main sentinel cells of innate immunity 
(epithelial, phagocytic and dendritic cells) express unique combinations of PRRs, which 
likely result in tissue-specific responses to pathogen (64). It is the stimulation of complex 
sets of pattern recognition receptors that induce an effective immune response. For 
example, cooperative signaling between the C-type lectin, Dectin-1 and TLR2 enhance 
the innate response to Candida albicans (47) and Mycobacterium tuberculosis (140), 
while cooperation between Mannose Binding Lectin (MBL) and TLR2/6 signaling from 
within the phagosome enhance the response to Staphylococcus aureus (63). Thus, 
multiple PRRs contribute to defining pathogen-specific innate immune responses. 
TLRs collectively recognize conserved lipid, carbohydrate, peptide and nucleic-
acid structures expressed by different groups of microorganisms. B. burgdorferi does not 
contain LPS, in contrast with other members of the spirochete group and therefore, does 
not engage TLR4.  The most important pattern recognized by innate immune receptors is 
constituted by the triacylated outer-surface lipoproteins of the spirochete and this seems 
to be true for whole spirochetes and lysates. It is not clear what the specific interaction 
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between whole spirochetes and antigens exposed by bacterial lysis with immune cells is 
in vivo. However, it is conceivable that both elicit immune responses since B. burdorgferi 
is likely to die in vivo, for example in the presence of antibody in a process that does not 
required complement or phagocytosis (34, 41, 89). 
The interaction of B. burgdorferi lipoproteins with complexes formed by TLRs 1 
and 2 on the surface of innate immune and other cell types initiates a series of 
incompletely defined signaling cascades that results in the production of proinflammatory 
cytokines (IL-1β, TNFα, IL-12, and IL-18, among others), chemokines (IL-8, MCP-1, 
KC), metalloproteinases and adhesion molecules (E-selectin, VCAM-1 and ICAM-1) 
(56). These proteins mediate the inflammatory response to the spirochete through the 
production of proinflammatory cytokines and chemotactic factors that further induce the 
recruitment of inflammatory cells. In addition TLR1/2 complexes also modulate adaptive 
immune responses, through increased antigen presentation, induction of costimulatory 
signals on antigen presenting cells and the production of cytokines that influence CD4+ T 
cell differentiation and effector function. Detection of B. burgdorferi lipoprotein is 
important for defining the in vivo response to B. burgdorferi, because TLR1-(2), TLR2- 
(137), or MyD88-deficient (18, 87) mice have significant increases in bacterial burden, 
compared to wildtype mice. Moreover, the development of arthritis in the absence of 
TLRs, CD14 (13) or MyD88 suggests that TLR-independent PRRs exist that trigger the 
inflammatory response to the spirochete. So, although innate sensing of the spirochete 
has solely been attributed to its recognition by TLR2/1 heterodimer complexes, the TLR 
response is likely amplified and further defined by cooperation with additional PRRs, 
which may or may not occur within the phagosome. Indeed, the induction of a potentiated 
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inflammatory response following phagocytosis of B. burgdorferi, compared to cell-
surface stimulation, indicates the existence of additional PRRs involved in the 
recognition of B. burgdorferi (35, 99). Whether this augmented response is the result of 
cooperative signaling with the phagocytic receptor or other PRRs recruited to the 
phagosome is unclear. 
Mechanisms of phagocytosis 
Phagocytosis is an evolutionary conserved phenomenon whereby large particles 
are ingested and destroyed via an extraordinarily complex process involving cognate 
receptors that distinguish foreign particles from self. While lower, single-celled 
organisms use phagocytosis primarily for the acquisition of nutrients, phagocytosis in 
multi-cellular Metazoans is carried out by specialized cells and is critical for the uptake 
and degradation of apoptotic cells and infectious agents. The contribution of phagocytosis 
to Lyme disease pathogenesis has not been studied, primarily because the mechanisms 
involved in this process have yet to be elucidated. Presumably, this cardinal mechanism 
of bacterial clearance is necessary for control of B. burgdorferi infection prior to and 
following the development of the adaptive immune response.  
 Phagocytic cells possess several pathways of phagocytic uptake, which vary 
depending on the origin of the phagocytic signal. Opsonin-dependent pathways are 
mediated by FcR and complement receptors, including complement receptor 3 (CR3, 
CD11b/CD18 or Mac-1), which was shown to mediate phagocytosis of non-specifically 
opsonized B. burgdorferi by human polymorphonucleocytes. Opsonin-independent 
phagocytosis can be mediated by multiple pattern recognition receptors, including C-type 
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lectins, scavenger receptors and integrins. Following adherence of the pathogen to the 
phagocytic cell through receptor interaction, phagocytic uptake is initiated by F-actin 
remodeling. Actin remodeling at the site of attachment is required for all forms of 
phagocytosis. The signaling cascade involved in the reorganization of actin is highly 
dynamic and can vary depending on which receptor(s) the phagocytic signal emanates 
from. Following attachment and actin remodeling, particles are internalized into 
phagosomes. It is here that microbial destruction and antigen presentation are initiated, 
through subsequent fusions with acid rich vesicles called lysosomes. 
Recruitment of phagocytic cells 
 The recruitment of phagocytic cells into sites of infection precedes the 
phagocytosis and destruction of pathogenic organisms. Recruitment is mediated by the 
production of chemokines, increased vascular permeability and upregulated expression of 
cell adhesion molecules in endothelial cells. B. bugdorferi induces the upregulation of 
these factors in different cell types. Chemokine production at sites of pathology in disease 
susceptible C3H/HeJ mice and –resistant C57BL/6J mice show that inflammation is 
related to increased production of neutrophil and monocyte-macrophage chemokines, KC 
and MCP-1, respectively (21). In Lyme disease patients, the production of chemokines, 
especially IL-8, during the initial response to B. burgdorferi correlates well with the onset 
of symptoms known to occur during the early stages of infection, suggesting that their 
production is increased during the beginning of the infection to recruit phagocytic cells, 
which are involved in the initial clearance of the spirochete. Overall, these results also 
suggest that the chemokine response is modulated once the infection progresses, and that 
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progression of the disease may be dependent on the regulation of these chemoattractants 
whose production might be altered by the presence of the infiltrating cells. 
Complement opsonization 
In addition to initiating the alternative pathway of complement activation and 
MAC-mediated lysis of microbes, C3b acts as a serum opsonin that enhances the 
phagocytic ingestion and destruction of microbes through recognition by Complement 
Receptor 1 (CD35) (113). The members of the pathogenic B. burgdorferi sensu lato 
group have evolved a variety of mechanisms enabling them to escape complement-
mediated lysis, including the expression of complement regulator-acquiring surface 
proteins (CRASPs), which serve as binding sites for the complement inhibitor factor H 
and factor H-like protein 1 (FHL-1) (59, 73, 74). Expression of CRASPs ultimately 
results in the cleavage of bound serum complement protein C3b into the serum opsonin 
inactivated C3b (iC3b), which is recognized by Complement Receptor 3 (CR3, 
CD11b/CD18, Mac-1). Thus, although the spirochete has evolved mechanisms to evade 
MAC-mediated lysis through the cleavage of C3b, this very mechanism could also 
generate iC3b fragments in close proximity to the B. burgdorferi organism making 
complement-mediated phagocytosis through CR3 a particularly relevant form of host 
defense against the invading and disseminated spirochete.  
Complement Receptor 3 
 CR3 (CD11b/CD18) is a transmembrane glycoprotein of the β2 integrin family 
with multiple substrate specificity that is primarily found on phagocytic cells. The 
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multifarious nature of CR3 is borne from its molecular structure, which consists of two 
distinct functional domains in the extracellular portion of the CD11b subunit. One such 
domain, the inserted domain (I-domain), of CR3 binds iC3b and intercellular adhesion 
molecule-1 (ICAM-1), among others, and thus participates in opsonin-mediated 
phagocytosis and diapedesis, respectively (114). The other domain, called the lectin-like 
domain (LLD), of CR3 mediates binding to several polysaccharide-containing pathogen 
associated molecules, such as filamentous hemagglutinin (FHA) of Bordetella pertussis 
and zymosan of Saccharomyces cerevisiae, where it participates in the formation of 
transmembrane signaling complexes with GPI-anchored glycoproteins resulting in 
adhesion, degranulation or phagocytosis (40). In addition, CR3 has been shown to 
mediate the phagocytosis of Neisseria meningitidis (66) and Bacillus anthracis spores 
(102) by macrophages. Overall, the extensive binding repertoire of CR3 facilitates 
intercellular interactions that are important for immunological maintenance of the host. 
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Materials and Methods      
Mice 
C57Bl/6 mice were bred at UMass Amherst. TLR2-deficient and CD11b-deficient 
C57Bl/6 mice were purchased from Jackson laboratories. The Institutional Animal Care 
and Use Committee at UMass Amherst approved all procedures involving animals. 
Cell culture and stimulations 
Bone marrow-derived macrophages were generated as described previously (104). 
Briefly, bone marrow cells were collected from the femoral shafts of wildtype or CD11b-
deficient C57Bl/6 mice and cultured in 20% L929-conditioned RPMI 1640 supplemented 
with 10% FCS (Hyclone), 2.4 mM L-glutamine and 10% penicillin-streptomycin 
(Invitrogen) in 100mm x 15mm petri dishes (Fisher Scientific) for 8 days at 37º C with 
5% CO2. Following incubation, non-adherent cells were eliminated and adherent 
macrophages scraped, counted and resuspended in serum-free RPMI medium without 
antibiotics overnight prior to use. Where indicated, 106 wildtype, TLR2- or CD11b-
deficient BMMs per mL were used for stimulation with different MOIs of live or 
sonicated B. burgdorferi in the absence or presence of wildtype or C3-deficient normal 
mouse serum (NMS) for 12h. Following stimulation, TNF secretion was determined by 
ELISA. 
The CHO cells transfected with human CR3 or CR4 were maintained in Ham's F-
12 medium supplemented with 10% FCS and 10% penicillin-streptomycin. 24 hours prior 
to use, the cells were washed and resuspended in FCS- and penicillin-streptomycin-free 
Ham's F-12. 
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The macrophage-like RAW264.7 cells were maintained in RPMI 1640 
supplemented with 10% FCS, 2.4 mM L-glutamine and 10% penicillin-streptomycin, as 
described. RAW264.7 cells were washed and resuspended in FCS- and penicillin-
streptomycin-free Ham's F-12, 24 hours before use. 
Bacteria 
GFP-expressing B. burgdorferi was generated by stably inserting a GFP-pflaB 
construct into the bbb20-bbb21 intergenic region of the virulent parental strain 297 (clone 
CE162). The GFP-expressing B. burgdorferi clone is completely stable even without 
antibiotic selection. Furthermore, the strain is comparable in virulence to the parental 
strain by needle inoculation and goes through the tick-mouse cycle as efficiently as the 
parental strain. A complete characterization of the clone, BB914, has been made and is 
the subject of a forthcoming manuscript (Ems et al. in preparation). The bacteria were 
cultured in BSK-II (Sigma) medium at 33ºC and used at log phase of growth. 
CR3 receptor blocking 
Before co-culture of B. burgdorferi with CHO cells or macrophages, cells were 
incubated for 15 minutes with 1, 10 or 20 µg ml-1 of rat anti-mouse CD11b clone M1/70 
antibodies (BD Pharmingen). For control experiments, cells were preincubated with 10 
µg ml-1 of rat anti-mouse CD11a clone M1/74 (BD Pharmingen) or Armenian Hamster 
anti-mouse CD11c clone HL3 (BD Pharmingen). Alternatively, cells were cultured in the 
presence of .1 or 1mM EDTA (Sigma) during incubation with B. burgdorferi to chelate 
divalent cations, including Mg2+, and to block ligand binding to the inserted domain of 
CR3. 
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Phagocytosis assay 
Internalization of B. burgdorferi was determined by a combination of flow 
cytometry and fluorescence microscopy. CHO-cells or macrophages (106 ml-1) were 
cultured in fetal calf serum-free and antibiotic-free medium with B. burgdorferi in the 
absence or presence of 5% normal mouse serum at different MOIs for 6h, except where 
indicated. Following incubation of the cells with B. burgdorferi, the cells were washed 
extensively and resuspended in PBS supplemented with 10% FCS and analyzed by flow 
cytometry or were further prepared for microscopic analysis. 
 To confirm phagocytosis, cells were examined by fluorescence microscopy. 
Following incubation of cells with bacteria, the cells were washed extensively and fixed 
in 3.7% para-formaldehyde for 7 minutes and then washed with PBS. The cells were then 
permeabilized with 0.1% Triton-X for 5 minutes and washed in PBS. Following blocking 
of non-specific binding with 5% BSA for 60 minutes, the permeabilized cells were 
stained with rhodamine phalloidin to visualize the actin skeleton for 30 minutes at 37ºC 
and DAPI to stain the nuclei (Molecular Probes) for 5 minutes at 37ºC. After extensive 
washing in PBS, the cells were mounted with Prolong Gold Anti-fade mounting reagent 
(Molecular Probes). Photographs were taken using a Zeiss Axiovert 200M inverted 
microscope (Thornwood, NY) equipped with a Hamamatsu Orca camera (Bridgewater, 
NJ). 
Analysis of CR3 expression 
The relative expression of CD18 and CD11b in RAW264.7 cells following 
activation of 106 cells with 100 ng/ml rmIFNγ was determined using total RNA extracted 
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from harvested cells using the TRIzol reagent (Invitrogen, Carlsbad, CA) according to the 
manufacturer's instructions. The RNA was treated with DNase I (Promega, Madison, 
WI), and reverse transcribed using random primers (Invitrogen) and SuperScript II 
reverse transcriptase (RT) (Invitrogen). The cDNA was amplified using primers specific 
for glyceraldehyde 3-phosphate dehydrogenase (gadph; 5’-CCA TCA CCA TCT TCC 
AGG AGC GAG-3’ and 5’-CAC AGT CTT CTG GGT GGC AGT GAT -3’), cd18 
(cd18; 5'-CGG TCT TCG ACT TGA AGT GAC CTG-3' and 5'-GGG TCC ATG ATA 
TCA TCG GC-3') and cd11b (cd11b; 5'-GGG TCC AGA AAC CTA ACT ACG TC-3' 
and 5'-CCA GTG TAT AAT TGA GGC GC-3') in an Mx3005P® QPCR System 
(Stratagene, La Jolla, CA) and SYBR green-containing reaction buffer (Roche, Nutley, 
NJ). Relative expression of the gene is referred to non-activated RAW264.7 cells. 
We confirmed elevated levels of CR3 expression by RAW264.7 cells following 
activation with IFNγ by flow cytometry and fluorescence microscopy. Following 
activation with rmIFNg, RAW264.7 cells were harvested and washed with PBS before 
incubation with FITC-conjugated rat anti-mouse CD11b (BD Pharmingen) for 30 minutes 
at 4ºC. The cells were next washed extensively and resuspended in PBS supplemented 
with 10% FCS and analyzed by flow cytometry for the expression of CR3.  
For the microscopic analysis of CR3 expression, the IFNγ-activated or non-
activated cells were washed extensively and fixed in 3.7% para-formaldehyde for 7 
minutes and then washed with PBS, as described. Following blocking of non-specific 
binding with 5% BSA for 60 minutes, the cells were stained with FITC-conjugated rat 
anti-mouse CD11b (Molecular Probes) for 60 minutes at 37ºC and DAPI, as described 
before. After extensive washing in PBS, the cells were mounted and analyzed. 
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Statistical analysis 
 The results are presented as means ± SE. Significant differences between means 
were calculated with the Student’s t test. P values of 0.05 or less were considered 
statistically significant.
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Results and Discussion 
Complement opsonization enhances phagocytosis of B. burgdorferi in a CR3-
dependent fashion 
The binding of complement-opsonized B. burgdorferi to human neutrophils has 
been shown to occur via a CR3-dependent mechanism (29). CR3-mediated phagocytosis 
of B. burgdorferi might be a particularly relevant mode of bacterial clearance during 
initial deposition of the spirochete into the skin and also during disseminated disease. 
This is because B. burgdorferi express surface exposed proteins that halt the terminal 
complement cascade by cleaving and inactivating C3b. This process generates iC3b, a 
serum opsonin and ligand for CR3, in close proximity to the pathogen. We therefore 
tested the role of complement opsonization in the phagocytosis of B. burgdorferi by 
murine BMMs. Incubation of GFP-expressing B. burgdorferi with BMMs in the presence 
of 10% normal mouse serum (NMS) greatly increases the amount of phagocytosis, as 
determined by immunofluorescence microscopy and flow cytometric analysis (Figures 
2.1A and B). To determine the contribution of CR3 and CR4 in mediating the interaction 
with complement opsonized B. burgdorferi, we utilized CHO cells expressing either CR3 
or CR4. Our results demonstrate that CR3 but not CR4 binds complement-opsonized B. 
burgdorferi, as previously demonstrated (29) (Figure 2.1C). Using a CR3 blocking 
antibody directed to the CD11b beta chain, we determined the contribution of CR3 to the 
phagocytosis of serum opsonized B. burgdorferi by RAW264.7 macrophage-like cells. 
The enhanced level of phagocytosis of B. burgdorferi in the presence of complement was 
abrogated by CR3 blocking, indicating that CR3 is the primary complement receptor 
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involved in the phagocytosis of complement opsonized B. burgdorferi (Figure 2.1D). Our 
results also show residual binding of B. burgdorferi to CHO-CR3 cells in the presence of 
heat-inactivated serum (Figure 2.1C), suggesting that CR3 may represent a means of 
interacting with B. burgdorferi at the host-cell/spirochete interface in the absence of 
complement. Furthermore, CR3 blocking reduced the level of B. burgdorferi 
phagocytosis in the presence of heat-inactivated NMS (Figure 2.1D), suggesting that this 
receptor may mediate the phagocytosis of the spirochete through a direct interaction.  
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Figure 2.1. Complement opsonization enhances phagocytosis of B. burgdorferi in a 
CR3-dependent fashion. 
 
(A) Microscopic and (B) flow cytometric analysis of B. burgdorferi phagocytosis 
by BMMs in the absence or presence of 10% NMS. F4/80 (red) was used as a cell-
surface marker and Dapi (blue) was used to stain the nucleus. (C) Increased B. 
burgdorferi interaction with CR3-expressing CHO cells in the presence of active or heat-
inactivated 10% NMS. (D) Anti-CD11b antibodies (10 µg/ml) inhibit the phagocytosis of 
B. burgdorferi by RAW264.7 cells in the presence of 10% NMS. Heat-inactivated serum 
was used to control for phagocytosis of B. burgdorferi proceeding in the absence of 
complement opsonization. A 4º binding control (solid gray histogram) was included and 
consists of B. burgdorferi incubated with RAW264.7 cells in the presence of 10% NMS.  
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CR3 is a receptor for B. burgdorferi 
Our assessment of the interaction between CR3 and B. burgdorferi in the absence 
of serum consisted of a combination of apotome microscopy and flow cytometry, as 
previously described (104). Our results show that CHO cells expressing CR3 acquire the 
ability to interact directly with B. burgdorferi, because CHO-CR3 but not CHO-CR4 
cells are positive for GFP fluorescence, above background binding, as determined by 
flow cytometric analysis (Figures 2.2A and B). In order to further elucidate the nature of 
the interaction between CR3 and B. burgdorferi, we analyzed the interaction of B. 
burgdorferi with CR3- or CR4-expressing CHO cells by fluorescence microscopy. These 
data confirmed our flow cytometric finding that CR3 facilitates the interaction of B. 
burgdorferi to CHO cells, but further suggested that CR3 expression alone is unable to 
confer phagocytic capacity to these cells (Figure 2.2C), because the spirochetes sustained 
their elongated morphology consistent with extracellular localization. We therefore 
utilized an immunoglobulin (Ig) protection assay to determine whether CHO cells 
expressing CR3 are able to internalize B. burgdorferi.  In this Ig protection assay, 
internalized spirochetes are protected from B. burgdorferi-specific Ig and therefore 
remain only GFP-positive while extracellular spirochetes will be stained with mouse B. 
burgdorferi-specific Ig and anti-mouse alexafluor 594 and therefore will be double-
positive.  Using this approach, we were unable identify CHO-CR3 cells that had 
internalized B. burgdorferi, indicating that CR3 is able to mediate cellular binding to B. 
burgdorferi but is not sufficient for phagocytosis of spirochete (Figure 2.2D). 
The most important integrin domain in ligand binding is the inserted (I) domain 
(84), which contains at their apex a metal-binding site known as the metal-ion-depending 
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adhesion site or MIDAS. The active conformation of CR3 requires the presence of a 
divalent cation in the inserted domain coordinated by the MIDAS. Mg2+ is the 
physiological metal that comprises integrin MIDAS, but Mn2+ is also able to orchestrate 
ligand binding in CR3 (82, 84, 97). Because CR3 binding to B. burgdorferi is disrupted 
by anti-CD11b antibody directed to the inserted domain (data not shown) and was 
previously shown not to depend on the lectin domain of CR3 (29), we tested whether this 
binding was dependent on free divalent cation. Using EDTA, a divalent cation chelator, 
we were able to completely disrupt the binding between CHO-CR3 cells and B. 
burgdorferi, indicating that CR3 MIDAS is required for binding to B. burgdorferi (Figure 
2.2E).
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Figure 2.2. CR3 is a receptor for B. burgdorferi. 
 
(A) Flow cytometric analysis of B. burgdorferi interaction with CR3- or CR4-
expressing CHO cells after 6h at an MOI of 10 or 100. Result is a single representative of 
three independent experiments. (B) Average percentage of B. burgdorferi associated 
CHO-CR3 and CHO-CR4 cells obtained from three separate experiments. (C) 
Microscopic analysis of CHO-CR3 or CHO-CR4 cellular interaction with B. burgdorferi. 
Cells were incubated with GFP-expressing B. burgdorferi at an MOI of 100. Rhodamine 
phalloidin was used to actin filaments (red) and the nucleus (blue) was stained with Dapi. 
(D) CHO-CR3 cells were incubated with GFP-expressing B. burgdorferi at and MOI of 
100 and extracellular spirochetes were stained with B. burgdorferi-infected mouse serum 
followed by anti-mouse IgG 594. The nucleus was stained with Dapi. (E) CHO-CR3 cells 
were incubated with B. burgdorferi at an MOI of 100 in the absence or presence of 1mM 
EDTA. 
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Phagocytosis of B. burgdorferi by macrophages is mediated by CR3 
Since CR3 is able to facilitate the attachment of B. burgdorferi to CHO cells 
(Figure 2.2), we hypothesized that CR3-mediated attachment could be important for 
phagocytosis of the spirochete by professional phagocytes, such as macrophages, in the 
absence of serum opsonization. We therefore determined the contribution of CR3 to the 
phagocytosis of B. burgdorferi by RAW264.7 macrophage-like cells by using the CR3 
blocking antibody that we previously demonstrated was able to disrupt the attachment of 
B. burgdorferi to CHO-CR3 cells and serum opsonized B. burgdorferi to RAW264.7 
cells. Anti-CD11a or -CD11c control antibodies do not affect phagocytosis of B. 
burgdorferi, while the presence of 5 µg/ml of anti-CD11b antibody results in a reduction 
in phagocytosis by approximately 50%, compared to the control group, as determined by 
flow cytometric analysis (Figure 2.3A) and microscopic analysis (Figure 3.3B). These 
data indicate that binding of B. burgdorferi by CR3 is important in mediating the 
phagocytosis of the spirochete by RAW264.7 cells.  
We next determined the contribution of CR3 in the phagocytosis of B. burgdorferi 
by bone marrow-derived macrophages, using RAW264.7 cells for comparison. The effect 
of the blocking antibody on the phagocytosis of B. burgdorferi by RAW264.7 cells is 
dose-dependent with complete inhibition occurring between 10-20 µg/ml of anti-CD11b 
(Figure 2.4A), underscoring the importance of this receptor in the phagocytosis of B. 
burgdorferi in this cell type. Importantly, the chelation of divalent cation with EDTA is 
also able to fully prevent phagocytosis of B. burgdorferi (Figure 2.4B), as expected. 
Although the effect of the blocking antibody on the phagocytosis of the spirochete by 
BMMs is also dose-dependent, the amount of inhibition is not as pronounced (Figure 
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2.4C). Even at a moderately high concentration, the effect of the blocking antibody on the 
phagocytosis of B. burgdorferi does not appear to reach a saturating level. Arguing that 
higher expression of the receptor requires a higher concentration of blocking antibody to 
achieve a similar level of inhibition between the two cell types, we determined the level 
of surface CR3 expression between RAW264.7 cells and BMMs. Indeed, expression of 
CR3 is more than 1 order of magnitude higher in BMMs, compared to RAW264.7 cells 
and EDTA does not affect CR3 expression in either cell type (Figure 2.4E). Moreover, 
the presence of EDTA is able to fully inhibit the phagocytosis of B. burgdorferi by 
BMMs when used at the same concentration with RAW264.7 cells (Figure 2.4D). We 
therefore utilized CD11b-deficient BMMs in our study to eliminate the effect of variable 
CR3 expression. Using CD11b-deficient macrophages, we are able to demonstrate that 
phagocytosis of B. burgdorferi is at least partially dependent on the presence of CR3 
(Figure 2.4F).
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Figure 2.3. CR3 mediates phagocytosis of B. burgdorferi by RAW264.7 cells. 
 
(A) Flow cytometric analysis or (B) microscopic analysis of RAW264.7 cell 
phagocytosis of B. burgdorferi in the presence of 5 µg/ml anti-CD11a, anti-CD11b or 
anti-CD11c at an MOI of 50 for 4h.  A 4º control was used to determine background-
binding levels. For microscopic analysis, rhodamine phalloidin was used to stain actin 
filaments (red) and the nucleus (blue) was stained with Dapi. 
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Figure 2.4. CR3 partially mediates the phagocytosis of B. burgdorferi by BMMs. 
 
RAW264.7 macrophages were incubated with GFP-expressing B. burgdorferi at 
an MOI of 50 for 4h in the absence (black histogram) or presence of increasing 
concentrations of (A) anti-CD11b antibody (green histogram) or (B) in the absence or 
presence of 1 mM EDTA. The shaded histogram indicates the 4º control. (C) Analysis of 
BMM phagocytosis of B. burgdorferi in (C) the presence of increasing concentrations 
anti-CD11b blocking antibody or (D) EDTA, as before, with the exception that 
spirochetes were used at an MOI of 10. (E) Analysis of CR3 expression in RAW264.7 
cells (green) and BMMs (blue) in the absence (solid histogram) or presence (dotted 
histogram) of 1 mM EDTA. (F) Widltype (black) and CR3-deficient BMMs (red) were 
incubated with B. burgdorferi at MOIs of 1 and 10, as before. For A-E, results depicted 
are representative of at least 3 experiments. For F, results are representative of 2 
experiments.
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IFNγ  upregulates CD11b and CD18 transcription resulting in increased CR3 cell 
surface expression and phagocytosis of B. burgdorferi 
We previously reported that IFNγ enhances phagocytosis of B. burgdorferi by 
RAW264.7 cells and BMMs (104). Although this phenomenon has important biological 
consequences in terms of infection, the mechanism underlying the IFNγ-mediated 
increase in spirochete phagocytosis is unknown. Now with a potential target, we 
determined the effect that IFNγ has on the expression of CD11b and CD18 by RAW264.7 
cells. Quantitative RT-PCR analysis of CD11b and CD18 in macrophages revealed that 
both of these transcripts were upregulated in response to IFNγ activation (Figure 2.5A). 
Since IFNγ increased CD11b and CD18 transcription, we next assessed the level of CR3 
protein on the surface of RAW264.7 cells. Microscopic analysis revealed that CR3 
expression is increased following activation with IFNγ, compared to non-activated 
control cells (Figure 2.5B). This finding was confirmed by flow cytometric analysis, 
which also demonstrated increased CR3 surface staining following IFNγ activation 
(Figure 2.5C).  
Because increased cell surface expression of CR3 could account for the IFNγ-
mediated increase in the phagocytosis of B. burgdorferi, we next determined the 
contribution of CR3 to the phagocytosis of B. burgdorferi by macrophages activated with 
IFNγ. As previously shown, IFNγ activation enhances the phagocytosis of B. burgdorferi 
by RAW264.7 cells (Figures 2.5D and E). However, the presence of anti-CD11b 
blocking antibodies significantly decreased the phagocytosis of B. burgdorferi by both 
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IFNγ-activated and non-activated RAW264.7 cells (Figures 2.5D and E). Importantly, 
our data demonstrate that the effect of IFNγ on the phagocytosis of B. burgdorferi is 
circumscribed to CR3 activity because disruption of CR3-mediated phagocytosis reduces 
phagocytosis to the same level in both IFNγ-activated and non-activated cells (Figures 
2.5D and E).  
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Figure 2.5. IFNγ  increases phagocytosis of B. burgdorferi through transcriptional 
upregulation of CR3 
 
(A) Quantitative real-time PCR analysis of CD11b and CD18 expression 
following activation RAW264.7 macrophages with (empty bars) or without (black bars) 
rmIFNγ for 12h. Determination of CR3 expression by fluorescence microscopy (B) and 
flow cytometry (C) following activation with or without rmIFNγ. For (C), the dashed line 
represents IFNγ-activated cells, and the gray line represents the non-activated cells. (D) 
Flow cytometric analysis of the role of CR3 in IFNγ-mediated enhancement of B. 
burgdorferi phagocytosis. Spirochetes were incubated with RAW264.7 cells at an MOI 
of 50 for 4h in the presence or absence of 50ng/ml rmIFNγ, as before. Anti-CD11b 
blocking antibody (red bar) or control anti-CD11c antibody (black bar) was used at 10 
µg/ml. The gray histogram is the 4ºC control and represents background binding. The 
results depicted here are representative of three experiments. (E) Graphical analysis of 
the average percentage of cells positive for B. burgdorferi phagocytosis. Results depicted 
are the average of 3 experiments. * Student’s T test, p<0.05
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CR3 is a negative regulator of proinflammatory cytokine induction in response to B. 
burgdorferi 
 Innate recognition of B. burgdorferi is mainly controlled by TLR1/2 complexes 
and results in the activation of an inflammatory gene profile. Having identified CR3 as a 
bonafide receptor for the spirochete, we next determined the contribution of the CR3-B. 
burgdorferi interaction to the TLR1/2-mediated response against B. burgdorferi by 
measuring the secretion of TNF in wildtype, TLR2- and CD11b-deficient BMMs. The 
secretion of TNF by wildtype BMMs challenged with live B. burgdorferi is almost 
completely abrogated in TLR2-deficient macrophages, confirming the predominant role 
for TLR1/2 complexes in the inflammatory response against the spirochete (Figure 2.6A). 
However, CD11b-deficient macrophages respond more vigorously to the spirochete 
compared to wildtype macrophages (Figure 2.6A), suggesting that CR3 is a negative 
regulator of TLR-induced TNF secretion. We next analyzed the contribution of CR3-
mediated signals derived from iC3b-opsonized B. burgdorferi to the secretion of TNF. 
Although phagocytosis of live B. burgdorferi potentiates TNF secretion, as compared to 
sonicated B. burgdorferi, and complement-opsonization increases phagocytosis of B. 
burgdorferi in a CR3-dependent fashion (Figure 2.1A-C), complement-opsonization 
significantly reduces the secretion of TNF by BMMs responding to live and sonicated B. 
burgdorferi (Figure 2.6B; Student t test; p < .05; n = 5). Furthermore, the effect of 
complement-opsonization on TNF secretion in response to live and sonicated B. 
burgdorferi was reversed by complement component C3-deficiency (Figure 2.6B), 
supporting a role for CR3 as a negative regulator of proinflammatory cytokine secretion 
in response to B. burgdorferi. Therefore, although phagocytosis of B. burgdorferi 
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potentiates the secretion of inflammatory cytokines (35), our data indicate that a B. 
burgdorferi phagocytic receptor, CR3, serves to modulate the TLR-mediated response 
against the spirochete by dampening the secretion of TNF. 
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Figure 2.6. CR3 is a negative regulator of cytokine induction in macrophages 
responding to B. burgdorferi. 
 
 (A) BMMs obtained from wildtype, TLR2-deficient or CD11b-deficient mice were 
incubated with B. burgdorferi at an MOI of 10 or 50 for 6h. TNF secretion was analyzed 
by ELISA. Results depicted are from a single experiment. (B) BMMs were incubated 
with live or sonicated B. burgdorferi at an MOI of 10 in the absence or presence of 10% 
NMS obtained from wildtype or C3-deficient mice. TNF secretion was determined by 
ELISA, as before. Results are representative of 5 (live B. burgdorferi) and 3 (sonicated B. 
burgdorferi) experiments. 
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CHAPTER IV 
CONCLUSION 
Invariant natural killer T cell responses are important for host protection during a 
variety of microbial infections (75). The discovery that B. burgdorferi-derived 
diacylglycerol glycolipids act as natural antigens to Vα14- and Vα24i NKT cells is the 
sole demonstration of an Vα14-Jα18i NKT cell antigen expressed by a human pathogen 
(68). The experimental infection of CD1d-deficient mice, which lack Vα14-Jα18i NKT 
cells, with B. burgdorferi also suggested their potential involvement in the genesis of 
inflammation during Lyme borreliosis. The absence of CD1d results in augmented B. 
burgdorferi levels in the urinary bladder of infected mice, in addition to increased Lyme 
arthritis incidence and severity (76), while the effect of CD1d-deficiency on Lyme 
carditis was not reported. However, these findings could not be assigned exclusively to 
Vα14-Jα18i NKT cell function, since CD1d-deficiency also leads to the lack of CD1d-
reactive cells other than Vα14-Jα18i NKTs (26, 27, 76). Furthermore, CD1d-deficient 
mice have impaired marginal zone B cell function (10), which may also affect the 
systemic response to the spirochete. These findings prompted us to examine the specific 
role of Vα14-Jα18i NKT cells in the pathogenesis of Lyme disease. 
Our studies, using a mouse line deficient for a component of the invariant alpha 
TCR, which specifically precludes the development of Vα14-Jα18i NKT cells in the 
thymus (75), show that infection of Jα18-deficient mice with B. burgdorferi results in 
higher pathogen burden in the heart and, as a consequence, more severe Lyme carditis. 
Although Vα14-Jα18i NKT cells are able to potentiate B cell responses to various 
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pathogens (127), our data indicate that this does not occur during infection with B. 
burgdorferi. Furthermore, Jα18-deficient mice infected with B. burgdorferi did not 
develop an altered Th1 response to B. burgdorferi antigens, as determined by antigen-
specific restimulation experiments. Thus, the effect of Vα14-Jα18i NKT-deficiency on 
the pathogenesis of murine Lyme disease is likely the result of the modulation of cell 
responses at sites of acute inflammation and not in secondary lymphoid organs. Indeed, 
we show that spirochete colonization and expansion in the heart leads to cardiac 
inflammation, which is marked by the migration to the heart of CD3+ T cells as well as 
CD1d- and CD11b- antigen presenting cells, while no infiltration of CD11c+ cells was 
detected (data not shown). Our data show that CD3+ T cells include Vα14-Jα18i NKT 
and other T cells (CD4+ and/or γδ T cells), because Jα18-deficient infected hearts still 
contained CD3+ cells (data not shown). 
Since B. burgdorferi glycolipid-pulsed dendritic cells induce IFNγ production by 
Vα14-Jα18i NKT cells in vivo (68), we tested the contribution of these cells to the pool 
of IFNγ mRNA found in the hearts of B. burgdorferi-infected mice. Our results show that 
induction of ifnγ gene expression in the hearts of B. burgdorferi-infected mice was almost 
completely abrogated in Jα18-deficient mice 2 weeks post infection, indicating that 
Vα14-Jα18i NKT cells are critical for generating an IFNγ response in vivo during the 
peak of disease. Reports have suggested that an intact IFNγ response is important for 
controlling pathogenesis of Lyme carditis and not Lyme arthritis (16, 20, 22, 52). 
Although the presence of T cells is not sufficient to prevent the onset of Lyme carditis 
(93), CD4+ T cells mediate the regression of murine Lyme carditis (16). Consistent with 
this, our results demonstrate that Vα14-Jα18i NKT cells are important for controlling the 
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severity of inflammation in the heart; a phenomenon circumscribed to their role in the 
production of IFNγ and modulation of the macrophage response to B. burgdorferi. Thus, 
we propose that the similar disease phenotype between IFNγRα- and Jα18-deficient mice 
is explained by the critical contribution of Vα14-Jα18i NKT cells to the pool of IFNγ 
found in the hearts of B. burgdorferi-infected mice. 
Studies have reported great variation among different inbred strains of mice in 
terms of the presence of Vα14-Jα18i NKT cells in different organs and their capacity to 
respond to antigen (116). Among a large panel of strains tested, Vα14-Jα18i NKT cells 
from B6 mice showed the highest production of cytokines and the fastest response 
kinetics to the prototypical ligand αGalCer (116). Since B6 mice are less susceptible to 
inflammation than C3H mice (141), and due to the difference in the number of Vα14-
Jα18i NKT cells and their response to specific antigen among these strains, it is tempting 
to speculate that the differential susceptibiltity to cardiac inflammation is associated with 
the presence and capacity of Vα14-Jα18i NKT cells to respond to B. burgdorferi 
antigens. Indeed, Tupin and coworkers recently demonstrated that iNKT cells do not 
migrate to the inflamed hearts of B. burgdorferi-infected BALB/c mice, and that Jα18-
deficient mice on the BALB/c background are not more susceptible to the development 
of Lyme carditis upon infection with B. burgdorferi (129). Whether these differences in 
quantity and/or their capacity to respond to antigen are also present in human subjects 
remains to be elucidated.  
A mechanism underlying IFNγ-mediated control of B. burgdorferi pathogenesis 
has not been determined. Since macrophages are the predominant leukocyte of the 
inflamed heart (115) and IFNγ activation of macrophages has been shown to enhance 
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their response to various pathogens (119), we determined the effect that IFNγ had on the 
macrophage response to B. burgdorferi. Our results indicate that IFNγ greatly enhances 
proinflammatory cytokine production by macrophages challenged with live B. 
burgdorferi. Most notably, IFNγ enhanced the phagocytic capacity of macrophages, 
suggesting their role in spirochete clearance at sites of active inflammation, such as the 
heart. This is an interesting observation given that IFNγ has historically been regarded as 
a cytokine with a biological activity confined to the response to intracellular pathogens, 
including viruses, bacteria and parasites. Here, we show that IFNγ is important for 
protection against the extracellular spirochete, B. burgdorferi. The lack of involvement of 
IFNγ in the pathogenesis of Lyme arthritis might be explained by the cellular profile of 
the inflammatory infiltrate. Indeed, lesions in the heart of B. burgdorferi infected mice 
are predominantly comprised of macrophages, while neutrophils are primarily found in 
the joint. The contribution of cell types such as synoviocytes, chondrocytes and other 
cells (9, 142) to joint but not heart inflammation further distinguish both inflammatory 
phenomena. As a consequence of the more complex cellular interplay, iNKT cell 
responses to B. burgdorferi in the joint might not be as effective at controlling Lyme 
arthritis. 
These studies define the role of Vα14-Jα18i NKT cells in the host response 
elicited against the Lyme disease spirochete, B. burgdorferi. Our results show that Vα14-
Jα18i NKT cells migrate to the inflamed heart of B. burgdorferi-infected mice and are 
exposed to an environment conducive for their activation by B. burgdorferi glycolipids. 
Activation of Vα14-Jα18i NKT cells is critical for the induction of IFNγ, which enhances 
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macrophage effector functions required for efficient clearance of B. burgdorferi from the 
inflamed heart and the sustained activation of Vα14-Jα18i NKT cells. 
 
The etiology of Lyme disease is not well understood. This is due, in part, to the 
complex interplay between different cell types, which varies depending on the affected 
site. Because macrophages are the principal immune cells found in the heart during 
experimental infection with B. burgdorferi (104, 115), the interaction between the 
macrophage and the spirochete has important consequences in terms of pathogenesis of 
Lyme carditis. However, the identification of a receptor that lies at the interface between 
the spirochete and macrophage and is able to mediate phagocytosis has remained elusive. 
Here we have identified the β2 integrin, CR3, as a receptor able to mediate the 
phagocytosis of B. burgdorferi in a complement- dependent and -independent manner 
and that CR3-dependent phagocytosis of B. burgdorferi is enhanced by activation with 
IFNγ.  
One of the main endogenous ligands of CR3 is the complement component iC3b 
(inactivated C3b), which is a serum opsonin with broad-range specificity for pathogens. 
Previous work demonstrated a role for CR3 in the phagocytosis of complement opsonized 
B. burgdorferi (29) by human neutrophils. Initial experiments here were in agreement 
with those findings because the phagocytosis of B. burgdorferi by RAW264.7 
macrophage-like cells and BMMs was dramatically enhanced by complement 
opsonization. Complement opsonization is not required for the phagocytosis of B. 
burgdorferi, however, and the addition of anti-CD11b blocking antibodies reduced the 
phagocytosis of complement-opsonized B. burgdorferi to levels below that achieved with 
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non-opsonized B. burgdorferi, suggesting that CR3 mediates the phagocytosis of B. 
burgdorferi in a complement-dependent and independent manner. 
When CHO cells were transfected with CR3 they acquired the ability to interact 
with B. burgdorferi, in the absence of complement opsonization. Studies using different 
pathogens, including N. meningitidis (66) and B. anthracis spores (102), showed that 
CR3 expression alone conferred phagocytic capacity for these pathogens to CHO cells. 
This is in contrast to our findings using B. burgdorferi, which show that the interaction 
between CR3-expressing CHO cells and B. burgdorferi is not productive in terms of 
phagocytosis, but instead is critical for attachment of the spirochete to the cell. These 
results indicated that CR3 is a B. burgdorferi receptor and suggested that the interaction 
between B. burgdorferi and CR3 might result in internalization of B. burgdorferi by a 
phagocytic cell. 
Our studies using RAW264.7 cells demonstrated that inhibition of CR3 with 
blocking antibody was able to completely abrogate phagocytosis of B. burgdorferi. Thus, 
CR3-mediated binding is a requirement for phagocytic uptake in this cell type. 
Interestingly, however, BMM phagocytosis of B. burgdorferi was only partially affected 
by inhibition of CR3-mediated binding, but completely blocked by the non-specific 
divalent cation chelator EDTA, suggesting the presence of alternative receptors that 
mediate binding through divalent cations. C-type lectins are a family of PRRs, including 
phagocytic receptors, whose binding to ligands usually proceeds in a Ca2+ dependent 
fashion. The mannose receptor (MR) is a C-type lectin that has been shown to mediate 
the binding of B. burgdorferi to human monocyte-derived macrophages (28). We 
speculate the involvement of MR in BMM phagocysosis of B. burgdorferi, based on the 
  75 
complete abrogation of phagocytosis in the presence of EDTA. In contrast, RAW264.7 
cell phagocytosis of B. burgdorferi is completely dependent on CR3. Importantly, 
preliminary studies in our lab have demonstrated that BMMs but not RAW264.7 cells 
express MR.  
CR3 is a promiscuous receptor that recognizes an array of host and microbial 
ligands. Outer surface lipoproteins A and B (OspA and OspB) are two major molecular 
constituents of B. burgdorferi, which contribute to the maintenance of the spirochete in 
nature but whose expression is downregulated during transmission into a mammalian 
host. These proteins were shown to bind to CR3 in an iC3b-independent fashion, 
suggesting that they may drive CR3-mediated phagocytosis (48). Moreover, experimental 
infection with an OspA/B-deficient mutant led to higher bacterial loads in the joint and 
more pronounced Lyme arthritis (143). An evaluation of Lyme carditis was not made in 
this study, but proliferation of the OspA/B mutant in the heart was statistically similar to 
that of the wildtype B. burgdorferi (143). Current studies are determining the contribution 
of Osps A and B to the phagocytosis of B. burgdorferi and whether this is dependent on 
an interaction with CR3. Preliminary results suggest that in BMMs the expression of 
Osps A and B are dispensible for the phagocytosis of the spirochete.  
We and others have shown that IFNγ-signaling is important for controlling the 
severity of Lyme carditis (16, 20, 22, 52, 104) via the modulation of macrophage-
mediated phagocytosis of B. burgdorferi (104). We show here that activation of 
macrophages with IFNγ resulted in upregulation of both components of CR3, CD11b and 
CD18, at the transcriptional level and that this correlated with increased cell surface 
expression of CR3. Importantly, the effect of IFNγ on the phagocytosis of B. burgdorferi 
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was completely diminished in the presence of CR3 blocking antibodies, indicating that 
the role of IFNγ in the phagocytosis of B. burgdorferi is circumscribed to the activity of 
CR3. 
Macrophages express unique combinations of PRRs, which likely result in tissue-
specific responses to pathogen (64). Because we defined CR3 as a receptor for B. 
burgdorferi, we were interested in the role of CR3 in defining the proinflammatory 
response to the spirochete. Our results indicate that CR3 is a negative regulator of the 
TLR1/2-induced signals elicited by B. burgdorferi, even in the context of complement. 
This is in contrast to most pathogens, in which complement opsonization increases the 
proinflammatory response and therefore our results warrant further investigation.  
In summary, we have defined the contribution of the complement receptor CR3 to 
the phagocytosis of the Lyme disease spirochete, B. burgdorferi. Our results place CR3 
as a central PRR involved in the recognition of B. burgdorferi by macrophages, because 
CR3 is able to mediate the phagocytosis of the spirochete. Our results also demonstrate 
that IFNγ regulates phagocytosis of B. burgdorferi by controlling the transcriptional 
activation of the components of CR3, CD11b and CD18. Furthermore, our results 
indicate CR3 is a negative regulator of TLR-induced proinflammatory signals elicited in 
response to B. burgdorferi both in the presence and the absence of complement 
opsonization. Taken together, these data shed light on the role of IFNγ and CR3 in 
macrophage-mediated control of spirochete expansion during Lyme borreliosis. 
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